Trial intelligence / Profile preview

Exenatide and Glucose Homeostasis in T2D

NCT00948168Phase 4Completed

Start
Jul 2008
Primary completion
Jul 2009
Modality
Peptides
Countries
1
01

Overview

A Phase 4 trial of exenatide in type 2 diabetes mellitus (T2DM). Started Jul 2008; status: completed.

02

Drugs

exenatide
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on NCT00948168.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00948168.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call